By: Ingrid Burke Friedman
The US Supreme Court on Thursday allowed the abortion drug mifepristone to remain available by mail and through telehealth nationwide, staying a Fifth Circuit order that had reinstated an in-person dispensing requirement while Louisiana's challenge to the drug's regulation proceeds in the lower courts.











